In addition, it could affect the development of pathogenic conditions, including hepatic steatosis, and increase the hepatic triglyceride content; the inhibition of NR1H3 contributes to the recovery from hepatocyte steatosis [47]. This evidence concerns the gene NR1H3 and Hepatic steatosis.